These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 22361658

  • 1. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S, Chandra Joshi S, Vir D, Agarwal A, Rao RD, Sridhar I, Xavier CM, Mathela CS.
    J Pharm Biomed Anal; 2012 Apr 07; 63():112-9. PubMed ID: 22361658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D, Basniwal PK.
    J Pharm Biomed Anal; 2013 Dec 07; 86():11-35. PubMed ID: 23969330
    [Abstract] [Full Text] [Related]

  • 4. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S, Mathela CS, Agarwal A, Paul SK.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):423-8. PubMed ID: 21676571
    [Abstract] [Full Text] [Related]

  • 5. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S, Shandilya S, Bharati A, Paul SK, Agarwal A, Mathela CS.
    J Pharm Biomed Anal; 2012 Jan 05; 57():39-51. PubMed ID: 21880452
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN, Maurya PK, Raju AN.
    J Pharm Biomed Anal; 2009 Jul 12; 49(5):1287-91. PubMed ID: 19376664
    [Abstract] [Full Text] [Related]

  • 11. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P, Subbarao DV, Vegesna RV, Sudhakar Babu K.
    J Pharm Biomed Anal; 2010 May 01; 52(1):142-8. PubMed ID: 20053517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comprehensive chemical analysis of Venenum Bufonis by using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hu Y, Yu Z, Yang ZJ, Zhu G, Fong W.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):210-20. PubMed ID: 21696903
    [Abstract] [Full Text] [Related]

  • 14. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG, Karmuse PP, Ghugare PD, Kanojiya SK, Rawal S.
    Rapid Commun Mass Spectrom; 2008 Jul 10; 22(14):2227-33. PubMed ID: 18543378
    [Abstract] [Full Text] [Related]

  • 15. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch, Jayaram P, Sunder Raj J, Saravana Kumar M, Bhargavi V, Handa VK, Dandala R, Naidu A.
    J Pharm Biomed Anal; 2008 Dec 01; 48(4):1211-8. PubMed ID: 18947955
    [Abstract] [Full Text] [Related]

  • 16. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch, Prasad ChS, Bharathi DV, Shankar R, Rao VJ, Dandala R, Naidu A.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):733-40. PubMed ID: 16950586
    [Abstract] [Full Text] [Related]

  • 17. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G, Corana F, Meneghetti O, Marazza F.
    J Pharm Biomed Anal; 2005 Sep 15; 39(3-4):757-63. PubMed ID: 15927438
    [Abstract] [Full Text] [Related]

  • 18. LC determination of glimepiride and its related impurities.
    Khan MA, Sinha S, Vartak S, Bhartiya A, Kumar S.
    J Pharm Biomed Anal; 2005 Oct 04; 39(5):928-43. PubMed ID: 16040224
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the trace-level impurities in the bulk drug citalopram by high-performance liquid chromatography/tandem multistage mass spectrometry.
    Sun C, Xu H, Pan Y, Shen Z, Wang D.
    Rapid Commun Mass Spectrom; 2007 Oct 04; 21(17):2889-94. PubMed ID: 17663502
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.